首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Drug Delivery

Drug Delivery杂志,由Informa Healthcare出版,于1993年创刊,Bimonthly,出版语言English,ISSN:1071-7544,E-ISSN:1521-0464。

投稿咨询
Drug Delivery
Drug Delivery
Drug Delivery
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
1区
影响因子
8
CiteScore
20.2
期刊收录
SCI、SCIE

Drug Delivery(中文译名:《药物输送》),ISSN:1071-7544,EISSN:1521-0464,是Informa Healthcare出版的国际性学术期刊,创刊于1993年,以Bimonthly形式稳定发行,2026年总发文量约85篇。该刊采用OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达8,2025年期刊CiteScore为20.2,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类1区TOP 期刊,在所属学科领域具备高学术影响力与国际认可度。Drug Delivery长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约3.0个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、Egypt、South Korea、Saudi Arabia、Iran、GERMANY (FED REP GER)等为核心发文国家与地区;CHINA PHARMACEUTICAL UNIVERSITYSHENYANG PHARMACEUTICAL UNIVERSITY、CAIRO UNIVERSITY、WENZHOU MEDICAL UNIVERSITY、YANTAI UNIVERSITY、FUDAN UNIVERSITY、SHANDONG FIRST MEDICAL UNIVERSITY & SHANDONG ACADEMY OF MEDICAL SCIENCES等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
1区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
1区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 24 / 356

93.4

学科:PHARMACOLOGY & PHARMACY SCIE Q1 12 / 356

96.77

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 17 / 352

95.3

学科:PHARMACOLOGY & PHARMACY SCIE Q1 9 / 353

97.59


中国学者近期发文

1
Overcoming the blood-brain barrier: nanomedicine strategies for targeted delivery and multimodal therapy in Alzheimer's diseas

Author:Li, Jiahui; Guo, Liting; Cai, Weiyi; Mei, Juanjuan; Liu, Jie; Liu, Yanan

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2645830

2
Angiopep-2-decorated bacterial outer membrane vesicles penetrate the blood-brain barrier for glioblastoma chemo-immunotherap

Author:Shah, Pir Tariq; Lou, Zhangrong; Zhu, Xiaojing; Jin, Wenrui; Chen, Chen; Hu, Tao; Guo, Peng; Zhao, Xuanzhu; Li, Fan; Yin, Xiaoliang; Wu, Zhenyong; Wu, Chengjun

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2660007

3
Unlocking the undruggable: current landscape and emerging frontiers in lysosomal receptor-mediated protein degradatio

Author:Ma, Yi-Meng; Xia, Hou-Fu; Xiao, Yi-Lei; Yu, Zi-Li

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2636323

4
Cerium oxide nanoparticles: antioxidant properties in silicosis treatment and biomedical application prospects-a dialectical consideratio

Author:Ban, Ge; Chen, Yuanjie; Zhao, Ran; Liang, Yingbing; Chen, Simo; Jia, Jingjing; Li, Chaoke; Sima, Jinwen; Ding, Dan; Wang, Xiaona; Zhu, Zhengkai; Han, Yumin

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2634421

5
Extracellular payload release from non-internalizing antibody-drug conjugates: mechanisms and linker technologie

Author:Feng, Chenxi; Lou, Rui; Chen, Shipeng; Lin, Furong; Ge, Jiaqi; Zhang, Yuwen; Lin, Chaolong; Huang, Chenghao

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2645769

6
Unlocking the potential of mesoporous silica nanoparticles: balancing biomedical applications and safety concern

Author:Hou, Yingze; Zhu, Can; Shen, Zhean; Cao, Desheng; Wei, Liangyu; Yang, Jiyu; Shi, Chaoyue; Wu, Meiqian; Zheng, Songyun; Chen, Yan; Zhou, Xianchun

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2624186

7
Re-engineering insulin for oral delivery: structural modifications, advanced formulation strategies, and future direction

Author:Zheng, Yilin; Fang, Xiaoyi; Gao, Jiangtao

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2624192

8
A macrophage-mimetic nanocarrier co-loaded with geraniol and FK13-a1 for MRSA-induced acute lung injur

Author:Li, Haonan; Xu, Binghong; Liang, Junguang; Hu, Tao; Wu, Tingting; Lai, Liqin; Zou, Xuan; Lv, Ziquan; Yao, Xiangjie; Jin, Xiaobao; Xu, Yinghua; Gui, Shuiqing; Lu, Xuemei

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2626104

9
Genetically engineered M13 phage-mediated H9N2 DNA vaccine with enhanced mucosal and systemic immune responses in mic

Author:Wang, Xiaohua; Zhao, Zhi; Shi, Mingze; Xu, Shangen; Zhou, Xin; Zhao, Kai

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2629037

10
ROS-triggerable dual nanocoated probiotics for inflammatory bowel disease treatmen

Author:Sang, Guangze; Wang, Sizhen; Tai, Qiwei; Zhang, Yunchang; Wang, Xufang; Yan, Baoling; Jiang, Weiwei; Chen, Zhendong; Sun, Linhong; Zhou, Jiao; Wu, Xiaoxian; Ye, Zi; Yang, Feng; Luo, Jun; Guo, Beibei

Journal: DRUG DELIVERY. 2026; Vol. 33, Issue 1, pp. -. DOI: 10.1080/10717544.2026.2630460


在线咨询

Drug Delivery

国际简称:DRUG DELIV参考译名:药物输送

年发文量:85 CiteScore:20.2 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:70.59%

杂志社联系方式:TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Drug Delivery